{"id":"https://openalex.org/W2166949035","doi":"https://doi.org/10.1016/j.jalz.2007.10.002","title":"Optimizing phase II of drug development for disease\u2010modifying compounds","display_name":"Optimizing phase II of drug development for disease\u2010modifying compounds","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2166949035","doi":"https://doi.org/10.1016/j.jalz.2007.10.002","mag":"2166949035","pmid":"https://pubmed.ncbi.nlm.nih.gov/18631992"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2007.10.002","doi":"https://doi.org/10.1016/j.jalz.2007.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2007.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2166949035"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060487287","display_name":"Jeffrey L. Cummings","orcid":"https://orcid.org/0000-0001-8944-4158","observed_orcids":["https://orcid.org/0000-0001-8944-4158"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey L. Cummings","raw_affiliation_strings":["Department of Neurology and Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060487287"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":1.0243,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.69708238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"4","issue":"1S1","first_page":"S15","last_page":"S20"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.649399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.649399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.32739999890327454,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proof-of-concept-studies","display_name":"proof-of-concept studies","score":0.734000027179718},{"id":"https://openalex.org/keywords/dose-finding-studies","display_name":"dose-finding studies","score":0.9610000252723694}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.7904197573661804},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5607511401176453},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5389078855514526},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5331674814224243},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5114923715591431},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5074288249015808},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.5018925666809082},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.4770440459251404},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47352978587150574},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.4578688144683838},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.41696658730506897},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.4151570200920105},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3510005474090576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34167689085006714},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34035712480545044},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.17730864882469177},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.13815739750862122},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09977799654006958},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jalz.2007.10.002","doi":"https://doi.org/10.1016/j.jalz.2007.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2007.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},{"id":"pmid:18631992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18631992","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & dementia : the journal of the Alzheimer's Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3830746813","display_name":"UCLA Alzheimer's Disease Research Center","funder_award_id":"P50AG016570","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320331479","display_name":"Fondation pour la Recherche sur Alzheimer","ror":"https://ror.org/01z0nmr69"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W64621832","https://openalex.org/W588403800","https://openalex.org/W1493908201","https://openalex.org/W1596756261","https://openalex.org/W1963500177","https://openalex.org/W1979121852","https://openalex.org/W1981458288","https://openalex.org/W1986710010","https://openalex.org/W1997417397","https://openalex.org/W2001032146","https://openalex.org/W2004537016","https://openalex.org/W2012552181","https://openalex.org/W2015514982","https://openalex.org/W2022489404","https://openalex.org/W2024719735","https://openalex.org/W2031309116","https://openalex.org/W2034892251","https://openalex.org/W2042277303","https://openalex.org/W2047416155","https://openalex.org/W2052132290","https://openalex.org/W2107820540","https://openalex.org/W2109031511","https://openalex.org/W2116602033","https://openalex.org/W2145369117","https://openalex.org/W2149142893","https://openalex.org/W2157064933","https://openalex.org/W2161212576","https://openalex.org/W2161966436","https://openalex.org/W2163057869","https://openalex.org/W2165840723","https://openalex.org/W2167720733","https://openalex.org/W2326200998","https://openalex.org/W2488375007","https://openalex.org/W3084756772","https://openalex.org/W4234060991","https://openalex.org/W4237232246","https://openalex.org/W4241686740"],"related_works":["https://openalex.org/W3207808020","https://openalex.org/W2162416868","https://openalex.org/W2015904620","https://openalex.org/W2158957241","https://openalex.org/W2121262334","https://openalex.org/W2997449274","https://openalex.org/W4214901860","https://openalex.org/W2800049094","https://openalex.org/W2147389067","https://openalex.org/W7100208466"],"abstract_inverted_index":{"Phase":[0],"II":[1,163],"proof":[2],"of":[3,33,64,130,144,169],"concept":[4],"(POC)":[5],"(IIa)":[6],"and":[7,28,46,49,135,164],"dose-finding":[8],"(IIb)":[9],"studies":[10,134],"represent":[11,114],"major":[12],"challenges":[13],"in":[14,26,150],"drug":[15,153],"development.":[16],"Prolonged":[17],"development":[18,154],"times":[19],"delay":[20],"effective":[21],"therapies":[22],"from":[23],"reaching":[24],"patients":[25],"need":[27],"adversely":[29],"affect":[30],"industry":[31],"goals":[32],"decreasing":[34],"time":[35],"to":[36,60,75,81,118,175,177],"market.":[37],"Biomarkers":[38],"including":[39],"magnetic":[40],"resonance":[41],"imaging,":[42],"cerebrospinal":[43],"fluid":[44],"tau":[45],"amyloid":[47,50],"beta,":[48],"positron":[51],"emission":[52],"tomography":[53],"have":[54,147,157],"been":[55,148],"considered":[56,126],"as":[57,127],"alternative":[58],"outcomes":[59],"clinical":[61],"measures.":[62],"None":[63,143],"these":[65,145],"is":[66,71,173],"yet":[67],"validated.":[68],"Population":[69],"enrichment":[70],"another":[72,115],"possible":[73],"solution":[74],"POC":[76,119],"studies.":[77,120],"More":[78],"rapid":[79],"progression":[80],"prespecified":[82],"milestones":[83],"can":[84],"be":[85,100],"achieved":[86],"by":[87],"enriching":[88],"the":[89,166],"population":[90],"with":[91,102,106,140],"risk":[92,182],"factors.":[93],"Conclusions":[94],"based":[95],"on":[96],"enriched":[97],"populations":[98],"must":[99],"extrapolated":[101],"caution.":[103],"Clinical":[104],"measures":[105],"greater":[107],"sensitivity":[108],"than":[109],"standard":[110],"trial":[111],"instruments":[112],"might":[113],"strategy":[116],"applicable":[117],"Adaptive":[121],"dose-response":[122],"designs":[123],"are":[124],"being":[125],"a":[128,137,151],"means":[129],"shortening":[131],"phase":[132,141,162,178],"IIb":[133],"creating":[136],"seamless":[138],"interface":[139],"III.":[142],"strategies":[146],"validated":[149],"successful":[152],"program;":[155],"all":[156],"some":[158],"promise":[159],"for":[160,183],"reforming":[161],"answering":[165],"central":[167],"question":[168],"\"how":[170],"much":[171],"information":[172],"sufficient":[174],"proceed":[176],"III":[179],"without":[180],"excessive":[181],"failure?\"":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2166949035","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
